Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

Similar articles for PubMed (Select 23161718)

1.

Simultaneous analysis of HER2 gene and protein on a single slide facilitates HER2 testing of breast and gastric carcinomas.

Hirschmann A, Lamb TA, Marchal G, Padilla M, Diebold J.

Am J Clin Pathol. 2012 Dec;138(6):837-44. doi: 10.1309/AJCPL5IV0LAWSERG.

2.

Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples.

Yan B, Yau EX, Choo SN, Ong CW, Yong KJ, Pang B, Salto-Tellez M.

J Clin Pathol. 2011 Oct;64(10):880-3. doi: 10.1136/jclinpath-2011-200009. Epub 2011 Jul 14.

PMID:
21757431
3.

Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.

Lim SJ, Cantillep A, Carpenter PM.

Hum Pathol. 2013 Nov;44(11):2590-6. doi: 10.1016/j.humpath.2013.07.005. Epub 2013 Sep 25.

PMID:
24075600
4.

Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia.

Fox SB, Kumarasinghe MP, Armes JE, Bilous M, Cummings MC, Farshid G, Fitzpatrick N, Francis GD, McCloud PI, Raymond W, Morey A.

Am J Surg Pathol. 2012 Apr;36(4):577-82. doi: 10.1097/PAS.0b013e318244adbb.

PMID:
22314190
5.

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.

Nitta H, Kelly BD, Padilla M, Wick N, Brunhoeber P, Bai I, Singh S, Ranger-Moore J, Bieniarz C, Tsuda H, Grogan TM.

Diagn Pathol. 2012 May 30;7:60. doi: 10.1186/1746-1596-7-60.

6.

Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?

Park YS, Hwang HS, Park HJ, Ryu MH, Chang HM, Yook JH, Kim BS, Jang SJ, Kang YK.

Hum Pathol. 2012 Mar;43(3):413-22. doi: 10.1016/j.humpath.2011.05.019. Epub 2011 Aug 19.

PMID:
21855114
7.

Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).

Kiyose S, Igarashi H, Nagura K, Kamo T, Kawane K, Mori H, Ozawa T, Maeda M, Konno K, Hoshino H, Konno H, Ogura H, Shinmura K, Hattori N, Sugimura H.

Pathol Int. 2012 Nov;62(11):728-34. doi: 10.1111/j.1440-1827.2012.02862.x.

PMID:
23121603
8.

Analytical validation and interobserver reproducibility of EnzMet GenePro: a second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast.

Downs-Kelly E, Pettay J, Hicks D, Skacel M, Yoder B, Rybicki L, Myles J, Sreenan J, Roche P, Powell R, Hainfeld J, Grogan T, Tubbs R.

Am J Surg Pathol. 2005 Nov;29(11):1505-11.

PMID:
16224218
9.

HER2 in situ hybridization in gastric and gastroesophageal adenocarcinoma: comparison of automated dual ISH to FISH.

Grin A, Brezden-Masley C, Bauer S, Streutker CJ.

Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):561-6. doi: 10.1097/PAI.0b013e3182849826.

PMID:
23455182
10.

Breast cancer HER2 equivocal cases: is there an alternative to FISH testing? A pilot study using two different antibodies sequentially.

Yosepovich A, Avivi C, Bar J, Polak-Charcon S, Mardoukh C, Barshack I.

Isr Med Assoc J. 2010 Jun;12(6):353-6.

11.

Where and by whom should gastric cancer HER2/neu status be assessed?: lessons from breast cancer.

Salto-Tellez M, Yau EX, Yan B, Fox SB.

Arch Pathol Lab Med. 2011 Jun;135(6):693-5. doi: 10.1043/2011-0084-ED.1. No abstract available.

PMID:
21631260
12.

Role of chromogenic in situ hybridization (CISH) in the evaluation of HER2 status in breast carcinoma: comparison with immunohistochemistry and FISH.

Li-Ning-T E, Ronchetti R, Torres-Cabala C, Merino MJ.

Int J Surg Pathol. 2005 Oct;13(4):343-51.

PMID:
16273190
13.

Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.

Tafe LJ, Janjigian YY, Zaidinski M, Hedvat CV, Hameed MR, Tang LH, Hicks JB, Shah MA, Barbashina V.

Arch Pathol Lab Med. 2011 Nov;135(11):1460-5. doi: 10.5858/arpa.2010-0541-OA.

PMID:
22032573
14.

HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab.

O'Malley FP, Thomson T, Julian J, Have C, Cosby R, Gelmon K, Andrulis I, Whelan T.

Arch Pathol Lab Med. 2008 Jan;132(1):61-5. doi: 10.1043/1543-2165(2008)132[61:HTIAPS]2.0.CO;2. Erratum in: Arch Pathol Lab Med.2008 May;132(5):730. Crosby, Roxanne [corrected to Cosby, Roxanne].

PMID:
18181675
15.

High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system.

Gown AM, Goldstein LC, Barry TS, Kussick SJ, Kandalaft PL, Kim PM, Tse CC.

Mod Pathol. 2008 Oct;21(10):1271-7. doi: 10.1038/modpathol.2008.83. Epub 2008 May 16.

16.

HER2 testing in breast carcinoma: very low concordance rate between reference and local laboratories in Brazil.

Wludarski SC, Lopes LF, Berto E Silva TR, Carvalho FM, Weiss LM, Bacchi CE.

Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):112-8. doi: 10.1097/PAI.0b013e3181f0b044.

PMID:
20930616
17.

Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study.

van Rooijen JM, de Munck L, de Graaf JC, Siesling S, de Vries EG, Boers JE.

Eur J Cancer. 2014 Mar;50(5):885-91. doi: 10.1016/j.ejca.2014.01.010. Epub 2014 Jan 31.

PMID:
24491395
18.

Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach.

Dekker TJ, Borg ST, Hooijer GK, Meijer SL, Wesseling J, Boers JE, Schuuring E, Bart J, van Gorp J, Mesker WE, Kroep JR, Smit VT, van de Vijver MJ.

Breast Cancer Res. 2012 Jun 13;14(3):R93.

19.
20.

HER2 status in gastric cancer: a comparison of two novel in situ hybridization methods (IQ FISH and dual color SISH) and two immunohistochemistry methods (A0485 and HercepTestâ„¢).

Pala EE, Bayol U, Ozguzer A, Akman O.

Pathol Res Pract. 2013 Sep;209(9):548-54. doi: 10.1016/j.prp.2013.05.008. Epub 2013 Jun 27.

PMID:
23910175
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk